A Multi-Center, Randomized, Double Blind, Active-Controlled, Parallel Group Clinical Study to Evaluate the Dose Effect of Intradermal Injections of Apitox vs. Histamine in Subjects With Osteoarthritis Symptoms of the Knee (HBV)

NCT00949754 Phase 2 COMPLETED

The study will evaluate Apitox, pure honeybee venom as a treatment for pain and inflammation of osteoarthritis of the knee.

Details

Lead sponsor	Apimeds, Inc.
Phase	Phase 2
Status	COMPLETED
Enrolment	40
Start date	2009-10
Completion	2010-04

Conditions

• Osteoarthritis of the Knee

Interventions

• honeybee venom (Apitoxin (Korea) Apitox (USA))

Primary outcomes

• WOMAC — 14 days

Countries

United States